Sigba, Juliana R.

HRN: 11-25-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2023
CEFTRIAXONE 1G (VIAL)
08/25/2023
09/01/2023
IV
2gms
OD
CAP MR
Checking Final Appropriateness 
08/25/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/25/2023
08/30/2023
PO
500mg
OD
CAP MR
Checking Final Appropriateness 
08/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2023
08/29/2023
IV
1 Dose As Loading Dose
Now Only
CAP-MR
Waiting Final Action 
08/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/29/2023
09/04/2023
IV
2.25mg
Q8hrs
CAP-MR
Waiting Final Action 
08/31/2023
LEVOFLOXACIN 500MG (TAB)
08/31/2023
09/11/2023
PO
500mg
Q24
Sepsis
Checking Final Appropriateness 
09/11/2023
CO-AMOXICLAV 625MG (TAB)
09/11/2023
09/17/2023
PO
625 Mg Tab, 1 Tab
TID
Cap-MR, Sepsis - (stepdown)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: